Literature DB >> 22695436

Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury.

Shahrokh Yousefzadeh Chabok1, Anoush Dehnadi Moghadam, Zahra Saneei, Fatemeh Ghazanfari Amlashi, Ehsan Kazemnezhad Leili, Zahra Mohtasham Amiri.   

Abstract

BACKGROUND: Diffuse axonal injury (DAI) is a common type of traumatic brain injury, mostly associated with mild changes on computed tomography (CT) scan. Serum biomarkers might be used in the diagnosis and prognosis of this injury type. Our purpose was to determine temporal profile and predictive values of serum concentrations of protein S100BB and neuron-specific enolase (NSE) after DAI.
METHODS: Twenty-eight isolated severe DAI patients (Glasgow Coma Scale score ≤ 8) with normal CT were enrolled in the study. Serum levels of S100BB and NSE were determined at 6 hours, 24 hours, 48 hours, and 72 hours after injury, using enzyme-linked immunosorbent assay. Clinical outcome variables of DAI comprised survival at discharge and Glasgow Outcome scale (GOS) after 3 months and also 2 years.
RESULTS: S100BB concentration was maximum in 6 hours after injury (median = 280.75 ng/L) followed by a quick drop. Its value was significantly higher on third day in patients with unfavorable outcome (GOS score = 1-3) versus favorable outcome (GOS score = 4, 5) (p < 0.0001). The values of NSE had mild changes during 3 days; however, these measured values at 72 hours after trauma manifested higher in unfavorable outcome (p < 0.05).
CONCLUSIONS: Increased serum concentrations of NSE and S100BB within first 3 days after DAI are associated with poor outcome despite mild CT findings. S100BB level at 72 hours after injury can predict late outcome in DAI patients. LEVEL OF EVIDENCE: Prognostic study, level III.
Copyright © 2012 by Lippincott Williams & Wilkins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695436     DOI: 10.1097/TA.0b013e318246887e

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  23 in total

1.  Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis.

Authors:  Eric Mercier; Amélie Boutin; Michèle Shemilt; François Lauzier; Ryan Zarychanski; Dean A Fergusson; Lynne Moore; Lauralyn A McIntyre; Patrick Archambault; France Légaré; François Rousseau; François Lamontagne; Linda Nadeau; Alexis F Turgeon
Journal:  CMAJ Open       Date:  2016-07-22

Review 2.  Post-traumatic Headache and Mild Traumatic Brain Injury: Brain Networks and Connectivity.

Authors:  Nasim Maleki; Alan Finkel; Guoshuai Cai; Alexandra Ross; R Davis Moore; Xuesheng Feng; X Michelle Androulakis
Journal:  Curr Pain Headache Rep       Date:  2021-03-05

Review 3.  Recommendations for the Critical Care Management of Devastating Brain Injury: Prognostication, Psychosocial, and Ethical Management : A Position Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Michael J Souter; Patricia A Blissitt; Sandralee Blosser; Jordan Bonomo; David Greer; Draga Jichici; Dea Mahanes; Evie G Marcolini; Charles Miller; Kiranpal Sangha; Susan Yeager
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

4.  The role of biomarkers in drug-resistant trigeminal neuralgia: a prospective study in patients submitted to surgical treatment.

Authors:  Alessandro Rapisarda; Silvia Baroni; Vanessa Gentili; Giacomo Moretti; Benedetta Burattini; Francesca Sarlo; Alessandro Olivi; Andrea Urbani; Nicola Montano
Journal:  Neurol Sci       Date:  2022-02-28       Impact factor: 3.307

5.  A correction formula for neuron-specific enolase measurement in hemolyzed neonatal serum samples.

Authors:  Qiang Wang; Guangrong Wang; Xiaolan Lu; Xiaolan Guo; Qin Du; Fang Lin; Quming Fan; Guoyuan Zhang; Dongsheng Wang
Journal:  Biomed Rep       Date:  2018-03-21

6.  Elevated neurofilament light chain (NFL) mRNA levels in prediabetic peripheral neuropathy.

Authors:  Asuman Celikbilek; Nermin Tanik; Seda Sabah; Elif Borekci; Lutfi Akyol; Hakan Ak; Mehmet Adam; Murat Suher; Neziha Yilmaz
Journal:  Mol Biol Rep       Date:  2014-04-15       Impact factor: 2.316

Review 7.  What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment.

Authors:  Cesar Reis; Yuechun Wang; Onat Akyol; Wing Mann Ho; Richard Applegate Ii; Gary Stier; Robert Martin; John H Zhang
Journal:  Int J Mol Sci       Date:  2015-05-26       Impact factor: 5.923

8.  Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome.

Authors:  Alex P Di Battista; John E Buonora; Shawn G Rhind; Michael G Hutchison; Andrew J Baker; Sandro B Rizoli; Ramon Diaz-Arrastia; Gregory P Mueller
Journal:  Front Neurol       Date:  2015-05-26       Impact factor: 4.003

Review 9.  The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis.

Authors:  Feng Cheng; Qiang Yuan; Jian Yang; Wenming Wang; Hua Liu
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

Review 10.  Monitoring biomarkers of cellular injury and death in acute brain injury.

Authors:  Sherry H-Y Chou; Claudia S Robertson
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.